Naslavsky Michel Satya, Vidigal Mateus, Matos Larissa do Rêgo Barros, Cória Vivian Romanholi, Batista Junior Pedro Benedito, Razuk Álvaro, Saldiva Paulo Hilário Nascimento, Dolhnikoff Marisa, Schidlowski Laire, Prando Carolina, Cunha-Neto Edécio, Condino-Neto Antonio, Passos-Bueno Maria Rita, Zatz Mayana
Universidade de São Paulo, Instituto de Biociências, Departamento de Genética e Biologia Evolutiva, Centro de Pesquisa sobre o Genoma Humano e Células-Tronco, São Paulo, SP, Brazil.
Instituto Prevent Senior, São Paulo, SP, Brazil.
Genet Mol Biol. 2021 Mar 1;44(1 Suppl 1):e20200302. doi: 10.1590/1678-4685-GMB-2020-0302. eCollection 2021.
COVID-19 comprises clinical outcomes of SARS-CoV-2 infection and is highly heterogeneous, ranging from asymptomatic individuals to deceased young adults without comorbidities. There is growing evidence that host genetics play an important role in COVID-19 severity, including inborn errors of immunity, age-related inflammation and immunosenescence. Here we present a brief review on the known order of events from infection to severe system-wide disturbance due to COVID-19 and summarize potential candidate genes and pathways. Finally, we propose a strategy of subject's ascertainment based on phenotypic extremes to take part in genomic studies and elucidate intrinsic risk factors involved in COVID-19 severe outcomes.
新型冠状病毒肺炎(COVID-19)包括严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的临床结果,具有高度异质性,从无症状个体到无合并症的年轻成年人死亡病例都有。越来越多的证据表明,宿主遗传学在COVID-19的严重程度中起重要作用,包括先天性免疫缺陷、年龄相关炎症和免疫衰老。在此,我们简要综述了已知的从COVID-19感染到严重的全身系统紊乱的事件顺序,并总结了潜在的候选基因和途径。最后,我们提出了一种基于表型极端情况的受试者确定策略,以参与基因组研究并阐明与COVID-19严重后果相关的内在风险因素。